For patients with type 2 diabetes, consumption of green tea and coffee is associated with reduced all-cause mortality.
Research used driving and reading to measure visual usefulness for patients with Wet AMD.
Investigators uncover which patients are more likely to misidentify their treatment eye.
Investigators evaluate the ocular impact of sodium-glucose co-transporter 2 (SGLT-2) inhibition on patients with type 2 diabetes.
Researchers have identified structural changes to the macula that are not associated with functional visual changes in some patients.
Research shows that point-of-care diabetic retinopathy screenings that provide immediate results and are likely to lead to an in-office exam for patients who need it.
Researchers found that, following anti-VEGF therapy, patients with DME mainted retinal thickness, but lost letters of visual acuity at 2 and 5 year follow-up appointments.
Researchers used OCT-A imaging to uncover microvasculature changes at peripapillary and parafoveal regions in patients with varying degrees of obstructive sleep apnea syndrome.
A study shows that behaviors associated with cardiovascular health can also help stave off ocular diseases, especially diabetic retinopathy.
EyeArt is the first FDA-cleared AI technology for autonomous detection of more than mild diabetic retinopathy and vision-threatening diabetic retinopathy.
Increased compliance with continuous positive airway pressure therapy may reduce the risk for the development of diabetic retinopathy in patients with type 2 diabetes who have obstructive sleep apnea.
A deep learning-enhanced device can accurately detect diabetic retinopathy.
Before the introduction of vascular endothelial growth factor inhibitors, laser photocoagulation was the standard of care for treatment of DME with or without preserved visual acuity.